Table 1.
Genes | Main Features and Mechanism | Cancer Types | References |
---|---|---|---|
IDH1/2 mutations | Accumulation of oncometabolites D-2HG, epigenetic alterations, and impaired mitochondrial respiration | Gliomas, glioblastomas, and AML |
[11,12,13,14,15,16,17,18,19,20] |
SDH mutations | Accumulation of succinate, inhibition of PHDs, and HIF1a stabilization | Pheochromocytoma, paraganglioma, and other cancers |
[21,22,23,24,25,26,27,28,29,30,31,32,33,34] |
FH mutations | Abnormal accumulation of fumarate, inhibition of PHDs, and HIF1a stabilization. Glutamine is used for heme synthesis. Glutamine is converted to aKG for citrate formation. Glutamine is also used to fuel TCA cycle and ATP production |
Papillary renal cell cancer, leiomyosarcoma, pheochromocytoma, paragangliomas, and other cancers | [35,36,37,38,39,40,41,42,43,44,45,46] |
SOD1-/- | Accumulation of O2-, abnormal mitochondria, oxidation of DNA, protein, and lipid, and decreased aconitase activity | Hepatocellular carcinoma | [47] |
SOD2+/- | Mitochondrial oxidative damage, nuclear DNA/ mtDNA oxidation, and decreased mitochondrial membrane potential | Lymphoma, pituitary adenoma | [48] |